This study followed 281 adults with asthma for 6 months to see if a triple-combination inhaler (BDP/FF/G) improves symptom control in everyday life. Participants had asthma for at least 3 years and were not well controlled on their current treatment. The main goal was to measure …
Sponsor: Chiesi Bulgaria • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC